|
OCIAD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.38764563675886E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.82676096471823E-12 |
| Normal-vs-Stage2 |
1.58496000000063E-05 |
| Normal-vs-Stage3 |
1.52740042835831E-10 |
| Normal-vs-Stage4 |
1.798210E-01 |
| Stage1-vs-Stage2 |
2.644200E-01 |
| Stage1-vs-Stage3 |
9.584600E-01 |
| Stage1-vs-Stage4 |
1.977700E-02 |
| Stage2-vs-Stage3 |
2.538000E-01 |
| Stage2-vs-Stage4 |
2.242600E-01 |
| Stage3-vs-Stage4 |
9.035900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.62534438633111E-12 |
| Normal-vs-AfricanAmerican |
1.02600039575407E-10 |
| Normal-vs-Asian |
3.53750000000597E-05 |
| Caucasian-vs-AfricanAmerican |
9.497800E-01 |
| Caucasian-vs-Asian |
5.941000E-01 |
| AfricanAmerican-vs-Asian |
5.766000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90181204118289E-12 |
| Normal-vs-Female |
8.58030313466429E-11 |
| Male-vs-Female |
3.228400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.13860000503652E-08 |
| Normal-vs-Extreme_Weight |
3.06865644006393E-13 |
| Normal-vs-Obese |
2.00560013041695E-10 |
| Normal-vs-Extreme_Obese |
3.646200E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.571800E-01 |
| Normal_Weight-vs-Obese |
9.475400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.491200E-01 |
| Extreme_Weight-vs-Obese |
2.035600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.076400E-01 |
| Obese-vs-Extreme_Obese |
6.709200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.116900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.37579947434574E-10 |
| Normal-vs-Age(61-80Yrs) |
1.69320113485583E-12 |
| Normal-vs-Age(81-100Yrs) |
8.46229997186754E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.011800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.409000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.137600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.097990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.409400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.704600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6251444634463E-12 |
| Normal-VS-Type2 PRCC |
1.24650001431803E-09 |
| Normal-VS-KIRP CIMP |
1.65234999999209E-05 |
| Normal-VS-Unclassified PRCC |
6.6912000051822E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.245370E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.338200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.582200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.895600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.363200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.522000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.41664499312355E-12 |
| Normal-vs-N1 |
5.231800E-04 |
| Normal-vs-N2 |
1.443640E-04 |
| N0-vs-N1 |
2.265200E-01 |
| N0-vs-N2 |
6.998600E-01 |
| N1-vs-N2 |
4.293600E-01 |
|
|
